Skip to content
Search

Latest Stories

‘Any abuse, violence or racism towards pharmacy staff is completely unacceptable’- GPhC

‘Any abuse, violence or racism towards pharmacy staff is completely unacceptable’- GPhC

GPhC urges employers to consider additional measure to reduce the risk of their staff experiencing abuse, violence or racism

The General Pharmaceutical Council (GPhC) has strongly condemned recent acts of racism, violence, and disorder caused by far-right, anti-immigrant protestors across the UK.

Roz Gittins, chief pharmacy officer at GPhC, expressed deep concern for the safety of pharmacy teams, particularly those from Black and minority ethnic backgrounds.


He said: “We strongly condemn the racism, violence and disorder caused by a small minority of the population that has taken place over recent days.”

“We understand that pharmacy teams serving our communities may feel especially vulnerable at this time."

“Pharmacists and pharmacy technicians from black and minority ethnic backgrounds, as well as those who trained abroad, make an enormous contribution to our pharmacy and health services and they should never have to feel fear when going to work.

“Any abuse, violence or racism towards pharmacy staff is completely unacceptable, and should be reported to the police.”

Gittins also urged employers to consider additional measures to protect their staff: “We recognise that employers have a duty of care to keep their staff safe at work and we urge pharmacy owners and other employers to urgently consider whether there are any further steps they could take to reduce the risk of their staff experiencing abuse, violence or racism.”

Employers are advised to ensure that pharmacy staff are not required to work alone, and to empower Responsible Pharmacists to make decisions such as temporarily closing a pharmacy if there are potential risks to the safety of the pharmacy staff, as well as the safety of patients and the public.

The GPhC also reminded employers and staff of the available support to protect their health and well-being during these challenging times.

“Our regulatory standards and guidance are there to help safeguard pharmacy staff, as well as patients and members of the public,” Gittins said.

The organisation encourages pharmacy owners, pharmacists and pharmacy technicians to seek further advice from their representative bodies and indemnity providers when necessary.

Pharmacy bodies including the Royal Pharmaceutical Society (RPS), Pharmacists’ Defence Association (PDA), National Pharmacy Association (NPA), Company Chemists’ Association (CCA), Independent Pharmacies Association (IPA), Guild of Healthcare Pharmacists and Association of Pharmacy Technicians UK are also offering advice and support to their members.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less